Use access key #2 to skip to page content.
$57.00 -0.62 (-1.08%)
10/10/2008 4:05 PM

Barr Pharmaceuticals, Inc. (BRL)

CAPS Rating:
*****

A specialty pharmaceutical Company, which is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals.

View All Commentary (BRL)

Recs

1

Avatar petejose (65.25) Submitted: 5/08/08 11:58 AM : Outperform Start Price: $38.05 BRL Score: 86.45

The basis for owning this (I have real money at a loss right now) is that the industry is in for long, appreciating demand with the population aging and the economy prepared for inflation. Recession money is decently sheltered in basic necessities, such as groceries, utilities, and pharmaceuticals. Demand is only going to grow and this price opportunity presents a buying opportunity, even if the wait for a significant rise is 6mos to a year away. Another example of the market overreacting to a downward adjustment of earnings in the near term.

Report this Post Replies: 0 | Reply

Featured Broker Partners